Literature DB >> 18419774

Chemotaxis of Entamoeba histolytica towards the pro-inflammatory cytokine TNF is based on PI3K signalling, cytoskeleton reorganization and the Galactose/N-acetylgalactosamine lectin activity.

Samantha Blazquez1, Ghislaine Guigon, Christian Weber, Sylvie Syan, Odile Sismeiro, Jean-Yves Coppée, Elisabeth Labruyère, Nancy Guillén.   

Abstract

Entamoeba histolytica is the protozoan parasite responsible for human amoebiasis. During invasive amoebiasis, migration is an essential process and it has previously been shown that the pro-inflammatory compound tumour necrosis factor (TNF) is produced and that it has a migratory effect on E. histolytica. This paper focuses on the analysis of parasite signalling and cytoskeleton changes leading to directional motility. TNF-induced signalling was PI3K-dependent and could lead to modifications in the polarization of certain cytoskeleton-related proteins. To analyse the effect of TNF signalling on gene expression, we used microarray analysis to screen for genes encoding proteins that were potentially important during chemotaxis towards TNF. Interestingly, we found that elements of the galactose/N-acetylgalactosamine lectin (Gal/GalNAc lectin) were upregulated during chemotaxis as well as genes encoding proteins involved in cytoskeleton dynamics. The alpha-actinin protein appeared to be an important candidate to link the Gal/GalNAc lectin to the cytoskeleton during chemotaxis signalling. Dominant negative parasites blocked for Gal/GalNAc lectin signalling were no longer able to chemotax towards TNF. These results have given us an insight on how E. histolytica changes its cytoskeleton dynamics during chemotaxis and revealed the capital role of PI3K and Gal/GalNAc lectin signalling in chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419774     DOI: 10.1111/j.1462-5822.2008.01158.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  19 in total

1.  Infection biology: Nibbled to death.

Authors:  Nancy Guillén
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

2.  Discrimination, crypticity, and incipient taxa in entamoeba.

Authors:  Avelina Espinosa; Guillermo Paz-Y-Miño-C
Journal:  J Eukaryot Microbiol       Date:  2012-02-02       Impact factor: 3.346

3.  Entamoeba histolytica rhomboid protease 1 has a role in migration and motility as validated by two independent genetic approaches.

Authors:  Elena Rastew; Laura Morf; Upinder Singh
Journal:  Exp Parasitol       Date:  2015-04-15       Impact factor: 2.011

4.  Entamoeba histolytica: Host parasite interactions at the colonic epithelium.

Authors:  Steve Cornick; Kris Chadee
Journal:  Tissue Barriers       Date:  2017-01-02

5.  The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.

Authors:  Shannon N Moonah; Mayuresh M Abhyankar; Rashidul Haque; William A Petri
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

Review 6.  Using differential gene expression to study Entamoeba histolytica pathogenesis.

Authors:  Carol A Gilchrist; William A Petri
Journal:  Trends Parasitol       Date:  2009-02-13

7.  Morphological and Motility Features of the Stable Bleb-Driven Monopodial Form of Entamoeba and Its Importance in Encystation.

Authors:  Deepak Krishnan; Sudip Kumar Ghosh
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

8.  A proteomic and cellular analysis of uropods in the pathogen Entamoeba histolytica.

Authors:  Jacques Marquay Markiewicz; Sylvie Syan; Chung-Chau Hon; Christian Weber; Daniela Faust; Nancy Guillen
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

9.  Glucose starvation boosts Entamoeba histolytica virulence.

Authors:  Ayala Tovy; Rivka Hertz; Rama Siman-Tov; Sylvie Syan; Daniela Faust; Nancy Guillen; Serge Ankri
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

10.  An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis.

Authors:  Devendra Bansal; Patrick Ave; Sophie Kerneis; Pascal Frileux; Olivier Boché; Anne Catherine Baglin; Geneviève Dubost; Anne-Sophie Leguern; Marie-Christine Prevost; Rivka Bracha; David Mirelman; Nancy Guillén; Elisabeth Labruyère
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.